PreprintAll rights reservedbioRxiv5 Oct 2026

KRAS-driven metabolic reprogramming of enhanced MFSD2A-mediated lysophosphatidylcholine scavenging promotes survival and progression of pancreatic ductal adenocarcinoma

y. chen
C. Haffner
B. Chellakkan Selvanesan
R. Wu
R. Ballaro
A. Vilchis Celis
M. Zuo
L. Patterson
M. Adofo
J. Vykoukal
R. Leon-Letelier
R. Dou

15 more authors

S. Park
Y. Cai
D. Rodriguez-Perera
E. Irajizad
F. McAllister
M. Kim
E. Koay
B. Wolpin
F. C. Hsiao
J. Dennison
H. Katayama
V. Bernard Pagan
A. Maitra
S. Hanash
J. Fahrmann¹

¹University of Texas MD Anderson Cancer Center

Read full text PDF DOI Cite

Epigenetic progression of pancreatic cancer to aggressive subtypes involves alternate routes of lineage reprogramming in subtype-intermediate progenitor cells
K. A. Hawthorne, J. R. Eng, M. Tsuda +12
bioRxiv28 Sep 2026PreprintAll rights reservedFull textOncologybioRxiv
Neoadjuvant chemotherapy induces transient, regimen-specific immune stromal reprogramming in pancreatic ductal adenocarcinoma
E. Minaei, D. Cox, A. S. Thind +13
bioRxiv7 Sep 2026PreprintCC BY-NDFull textOncologybioRxiv
Decoding lipid metabolic reprogramming in pancreatic ductal adenocarcinoma: from tumor–microenvironment crosstalk to therapeutic resistance
Xingyu Liu, Zitong Ye, Liuyang Wang +9
Frontiers in Oncology26 Oct 2026Peer-reviewedCC BY 4.0Full textOncologyCrossref
Lipid Metabolic Reprogramming and Chemoresistance in Pancreatic Ductal Adenocarcinoma: Insights From Lipidomics
Revathi Valliyodu, Diya Maria Siril, Harsha Sanil +9
Cell biochemistry and function1 Oct 2026Peer-reviewedCC BYFull textOncologyEurope PMCPMC
SPP1-CD44-Mediated Crosstalk Between Endothelial and Macrophage Subpopulations Promotes Pancreatic Ductal Adenocarcinoma Progression Through S100A6 Upregulation
Yanbin Zhou, Sixian Guo, Wenhu Zhou +1
Cells11 Oct 2026Peer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMC

Cite

BibTeX RIS

BibTeX

@misc{chen2026krasdriven,
  title = {{KRAS-driven metabolic reprogramming of enhanced MFSD2A-mediated lysophosphatidylcholine scavenging promotes survival and progression of pancreatic ductal adenocarcinoma}},
  author = {y. chen and C. Haffner and B. Chellakkan Selvanesan and R. Wu and R. Ballaro and A. Vilchis Celis and M. Zuo and L. Patterson and M. Adofo and J. Vykoukal and R. Leon-Letelier and R. Dou and S. Park and Y. Cai and D. Rodriguez-Perera and E. Irajizad and F. McAllister and M. Kim and E. Koay and B. Wolpin and F. C. Hsiao and J. Dennison and H. Katayama and V. Bernard Pagan and A. Maitra and S. Hanash and J. Fahrmann},
  howpublished = {bioRxiv},
  year = {2026},
  month = oct,
  doi = {10.64898/2026.10.05.756824},
  url = {https://www.biorxiv.org/content/10.64898/2026.10.05.756824v1},
}

RIS

TY  - UNPB
TI  - KRAS-driven metabolic reprogramming of enhanced MFSD2A-mediated lysophosphatidylcholine scavenging promotes survival and progression of pancreatic ductal adenocarcinoma
AU  - y. chen
AU  - C. Haffner
AU  - B. Chellakkan Selvanesan
AU  - R. Wu
AU  - R. Ballaro
AU  - A. Vilchis Celis
AU  - M. Zuo
AU  - L. Patterson
AU  - M. Adofo
AU  - J. Vykoukal
AU  - R. Leon-Letelier
AU  - R. Dou
AU  - S. Park
AU  - Y. Cai
AU  - D. Rodriguez-Perera
AU  - E. Irajizad
AU  - F. McAllister
AU  - M. Kim
AU  - E. Koay
AU  - B. Wolpin
AU  - F. C. Hsiao
AU  - J. Dennison
AU  - H. Katayama
AU  - V. Bernard Pagan
AU  - A. Maitra
AU  - S. Hanash
AU  - J. Fahrmann
PY  - 2026
DA  - 2026/10/05
PB  - bioRxiv
DO  - 10.64898/2026.10.05.756824
UR  - https://www.biorxiv.org/content/10.64898/2026.10.05.756824v1
ER  -

Related

Cite